We went on to test the ability of MYOCD to inhibit stemness of lung cancer on SCID mice through in vivo limiting dilution assay, a widely accepted method to determine the frequency of tumor initiating cell of an established cell line. This evidence concerns the gene MYOCD and neoplasm.